Psykey, Inc. (OTCMKTS:CEOS) Short Interest Down 79.8% in November

Psykey, Inc. (OTCMKTS:CEOS) was the target of a large decline in short interest in the month of November. As of November 15th, there was short interest totalling 2,400 shares, a decline of 79.8% from the October 31st total of 11,900 shares. Based on an average trading volume of 877,900 shares, the days-to-cover ratio is currently 0.0 days.

Psykey Stock Up 34.3 %

CEOS traded up $0.01 on Wednesday, hitting $0.03. 985,402 shares of the company traded hands, compared to its average volume of 575,104. Psykey has a 12-month low of $0.01 and a 12-month high of $0.05. The company has a 50 day moving average of $0.02 and a 200-day moving average of $0.02.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.